SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the updated COVID-19 vaccine (NVX-CoV2601) developed by Novavax, a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has received an emergen
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company’s board of directors has decided to invest in the expansion of L HOUSE, a vaccine manufacturing plant of SK bioscience located in Andong, South Korea to ap
On Nov. 27, Incheon Free Economic Zone Authority (IFEZ) announced that a delegation of 11 researchers, including Professor Han Nam-sik, AI Center Director at the Milner Research Institute affiliated with the University of Cambridge, and Senior Researcher Georgia Sakkoziorga visited IFEZ. They toured
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics research and development organization committed to
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that H.E Dr. Jean Kaseya, Director General of Africa CDC visited SK bioscience headquarters on November 3 to discuss collaboration with the Partnerships for African Vaccine
The author is an analyst for NH Investment & Securities. He can be reached at pk.park@nhqv.com -- Ed.Samsung Biologics’ separate 3Q23 OP surprised at W381.6bn, thanks to the ramp-up of plant #4 and improved efficiency and approval timing for batch orders. Now that the firm has reached a reason valua
During President Yoon Seok-yeol’s state visit to Saudi Arabia, a total of 46 memoranda of understanding (MOUs) and contracts were signed at the 2023 Korea-Saudi Investment Forum. This signifies a boost in economic cooperation between the two nations across various industries, including electric vehi
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced on the 20th that the application of the updated Novavax COVID-19 vaccine (NVX-CoV2601), developed by Novavax, a global company advancing protein-based vaccines with its Mat
McKinsey introduced the content of its report, “Koreas Next S-Curve,” to international media outlets at Shilla Hotel in Seoul on Oct. 19. In the report, the company proposed three pillars of reorganization, transformation, and construction and eight action items for Korea’s economic renaissance.McKi
President Yoon Suk-yeol will visit Saudi Arabia and Qatar on a four-day, six-night state visit starting on Oct. 21. This will mark the first time a Korean head of state has paid a state visit to Saudi Arabia and Qatar.President Yoon will arrive in Riyadh, the capital of Saudi Arabia, on Oct. 21 (loc
SK pharmteco will participate at the CPHI 2023 in Barcelona and prepare a dedicated booth at the event. As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pu
Korea and Saudi Arabia have agreed to expand cooperation in the biotech, gaming, and automotive sectors while implementing existing economic cooperation tasks in infrastructure.The Ministry of Trade, Industry and Energy (MOTIE) announced the agreement at the Four Seasons Hotel in Seoul, during the f
The ongoing armed conflict between Israel and the armed Palestinian faction, Hamas, has sent shock waves through the Middle East. Accordingly, major South Korean companies like Samsung Electronics and Hyundai Motor, which have a significant presence in the area, are closely monitoring the situation.
Daewoong Pharmaceutical is rapidly securing its position in the market by consecutively acquiring patents related to the treatment of autoimmune diseases. The company announced on Oct. 4 that it has registered three patents related to autoimmune disease treatments over the past six months.To date, D
Celltrion announced on Oct. 4 that it had obtained additional approval from the U.S. Food and Drug Administration (FDA) for 80mg/0.8mL and 20mg/0.2mL (hereinafter referred to as 80mg and 20mg) dosages of its Humira (active ingredient: adalimumab) biosimilar, Yuflyma (development code: CT-P17), on Se
Tensions and conflicts are intensifying in the “semiconductor war” between the U.S. and China. As the first anniversary approaches of the U.S. government’s decision to restrict exports of semiconductor chips and equipment to China on Oct. 7 of last year, an update on policies regarding “Artificial I
Celltrion announced on Sept. 19 that it is focusing on securing various platforms and pipelines including oral antibody therapeutics, antibody drug conjugates (ADCs), new antibody drugs, bispecific antibodies, microbiomes and anti-cancer virus platforms through development and research as well as op
The government is set to invest 400 billion won (US$301.66 million) next year and a total of 2.2 trillion won over the next five years to establish geographical zones dedicated to creating specific industries at world-class level. To boost the venture ecosystem, it plans to increase the external fun
Recent data shows that South Korea’s top revenue-generating corporations have collectively invested a total of 4.5 trillion won (US$3.38 billion) in stakes in other companies, including ventures and startups, over the past 2 years and 6 months. The sector that received the highest concentration of i
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that Ana Brnabić, Prime Minister of the Republic of Serbia (Serbia) has visited the SK bioscience headquarters and signed a memorandum of understanding (MOU) with the compa